Vishal Rajesh Patel
Physician in Washington, DC
License number
DC DR-0012165
Issued Date
Apr 12, 2017
Expiration Date
Jun 30, 2019
Category
Controlled Substances
Type
Physician CSR
Address
Address
2
Washington, DC 20010
Professional information
Patent Examiner At United States Patent &Amp; Trademark Office
Position:
Patent Examiner at United States Patent & Trademark Office
Location:
Washington D.C. Metro Area
Industry:
Chemicals
Work:
United States Patent & Trademark Office
since Oct 2008
-
Patent Examiner
GSE Systems
Aug 2006 - Oct 2008
-
Systems Engineer
Walter Reed Army Institute of Research
Oct 2004 - Aug 2006
-
Viral Research Associate
Xceed Molecular
Feb 2004 - Jun 2004
-
Research Associate
Education:
University of Maryland College Park 2005 - 2008
Masters, Masters of Engineering University of Pittsburgh 1999 - 2003
BS, Bioengineering
Masters, Masters of Engineering University of Pittsburgh 1999 - 2003
BS, Bioengineering
Interests:
Golf, Tennis, Stocks, Politics
Small Molecule Inhibitors Of Plasmodium Falciparum Dihydroorotate Dehydrogenase
US Patent:
2011013, Jun 2, 2011
Filed:
May 7, 2009
Appl. No.:
12/991305
Inventors:
Cecilia Bastos - South Grafton MA, US
Michael L. Booker - Bridgewater MA, US
Cassandra A. Celatka - Hull MA, US
Jon C. Clardy - Jamaica Plain MA, US
Joseph Cortese - Quincy MA, US
Vishal P. Patel - Washington DC, US
Renato Skerlj - Newton MA, US
Roger C. Wiegand - Wayland MA, US
Dyann F. Wirth - Boston MA, US
Michael L. Booker - Bridgewater MA, US
Cassandra A. Celatka - Hull MA, US
Jon C. Clardy - Jamaica Plain MA, US
Joseph Cortese - Quincy MA, US
Vishal P. Patel - Washington DC, US
Renato Skerlj - Newton MA, US
Roger C. Wiegand - Wayland MA, US
Dyann F. Wirth - Boston MA, US
International Classification:
A61K 31/5377, C07D 413/04, C07D 409/04, C07D 473/00, C07D 409/14, C07D 471/04, C07D 413/14, A61K 31/4025, A61K 31/4535, A61K 31/4184, A61K 31/4155, A61K 31/496, A61K 31/52, A61K 31/454, A61K 31/437, A61K 31/422, A61P 33/06
US Classification:
51421018, 544146, 548527, 546212, 5483047, 5483657, 544379, 544277, 5483061, 546199, 546118, 548217, 5483054, 548220, 5142315, 514422, 514326, 514394, 514406, 51425213, 51426323, 514322, 514303, 514375
Abstract:
Inhibitors of dihydroorotate dehydrogenase (DHODH) for the enzyme have been identified and characterized. The inhibitors have high specificity, submicromolar efficacy against cultured parasite strains, exhibit drug-like properties, and are not overtly cytotoxic.